SCHEMBL761789

SCHEMBL761789

CC(=S)Oc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA4 P22748 1/20 0.43
ELANE P08246 2/20 0.43
ALDH1A1 P00352 3/20 0.42
MAPT P10636 3/20 0.42
LTA4H P09960 1/20 0.41
TSHR P16473 1/20 0.41
TAS2R38 P59533 1/20 0.41
HSP90AA1 P07900 1/20 0.41
GAA P10253 1/20 0.41
ATM Q13315 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CA5A P35218 1/20 0.39
CA5B Q9Y2D0 1/20 0.39
EPHX1 P07099 1/20 0.38
CYP1A2 P05177 1/20 0.38
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2374211 0.97 ELANE (0.42) CA4ELANEALDH1A1MAPTLTA4H
SCHEMBL3384751 0.81 ALDH1A1 (0.46) ELANEALDH1A1MAPTHSP90AA1GAA
SCHEMBL27990554 0.80 ALDH1A1 (0.52) ALDH1A1MAPTL3MBTL1TDP1ALOX15
SCHEMBL27645257 0.79 CA4 (0.43) CA4ELANEALDH1A1MAPTLTA4H
SCHEMBL95954 0.78 CA4 (0.48) CA4ELANEALDH1A1MAPTLTA4H
SCHEMBL178607 0.78 LTA4H (0.45) CA4ALDH1A1MAPTLTA4HTSHR
SCHEMBL547579 0.78 CA4 (0.48) CA4ELANEALDH1A1MAPTLTA4H
SCHEMBL2470101 0.78 LTA4H (0.45) CA4ELANEALDH1A1MAPTLTA4H
SCHEMBL3087192 0.78 LTA4H (0.45) CA4ELANEALDH1A1MAPTLTA4H
SCHEMBL1679224 0.78 CA4 (0.48) CA4ELANEALDH1A1MAPTLTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113795499-B Process for producing alkoxysilyl group-containing thiocarboxylate 迈图高新材料公司 2024-03-19 CN claimed
CN-113795499-A Process for producing alkoxysilyl group-containing thiocarboxylic ester 迈图高新材料公司 2021-12-14 CN claimed
CN-103562245-A Novel diblock copolymer, method of preparing the same, and method of forming nanopattern using the same LG CHEMICAL LTD 2014-02-05 CN claimed
CN-103237822-A Novel acrylamide-ased mesoporous polymer and preparation method thereof LG CHEMICAL LTD 2013-08-07 CN claimed
CN-100426582-C Electrolyte for lithium battery and lithium battery comprising the same SAMSUNG SDI CO LTD (KR) 2008-10-15 CN claimed
US-20080213673-A1 ELECTROLYTE FOR LITHIUM BATTERY AND LITHIUM BATTERY COMPRISING THE SAME SAMSUNG SDI., CO., LTD (KR) 2008-09-04 US claimed
CN-100384821-C Cetp activity inhibitors JAPAN TOBACCO INC (JP) 2008-04-30 CN claimed
US-20050221197-A1 Electrolyte for lithium battery and lithium battery comprising the same SAMSUNG SDI CO., LTD. (KR) 2005-10-06 US claimed
CN-1677739-A Electrolyte for lithium battery and lithium battery comprising the same SAMSUNG SDI CO LTD (KR) 2005-10-05 CN claimed
US-6913856-B2 Sulfur compound as nonaqueous electrolyte SONY CORPORATION (JP) 2005-07-05 US claimed
CN-1252053-A Cetp activity inhibitors JAPAN TOBACCO INC (JP) 2000-05-03 CN claimed
US-20250171493-A1 PROCESSES FOR SYNTHESIS OF WITHANOLIDES AND WITHAFERINS AND ANALOGS THEREOF H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. 2025-05-29 US disclosed
CN-113795499-B Process for producing alkoxysilyl group-containing thiocarboxylate 迈图高新材料公司 2024-03-19 CN disclosed
WO-2023172499-A2 PROCESSES FOR SYNTHESIS OF WITHANOLIDES AND WITHAFERINS AND ANALOGS THEREOF H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2023-09-14 WO disclosed
CN-115521244-A Method for constructing carbon-sulfur/selenium bond through triazole compound and sulfur/selenide 四川大学 2022-12-27 CN disclosed
CN-1158126-A Process for preparing taxol and its derivatives PHARMACIA & UPJOHN SPA (IT) 1997-08-27 CN disclosed
CN-1109873-A Thioimidates, their preparation and their use BASF AKTEINGESELLSCHAFT (DE) 1995-10-11 CN disclosed
EP-0310484-A1 Derivatives of alkadienes, their preparations, medicinal compositions containing them, and intermediates RHONE-POULENC SANTE (FR) 1989-04-05 EP disclosed
US-4642352-A 7-ACYLAMINO-9A-METHOXY DERIVATIVES; ANIMAL ANTITUMOR AGENTS BRISTOL-MYERS COMPANY (US) 1987-02-10 US disclosed
CN-85103820-A 2-nitro-5 (2 '-chloro-4 '-the phenylfluoroform phenoxy group)-phenylacetate, thioesters and acid amides preparation method, weedicide and eliminate the method for injurious weed 1986-11-05 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250171493-A1 PROCESSES FOR SYNTHESIS OF WITHANOLIDES AND WITHAFERINS AND ANALOGS THEREOF ERG28, CYP51A1, HASPIN CA4 4002/4885ELANE 4114/4885ALDH1A1 2428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.